These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28749905)

  • 41. Long Non-Coding RNA SNHG6 as a Potential Biomarker for Hepatocellular Carcinoma.
    Birgani MT; Hajjari M; Shahrisa A; Khoshnevisan A; Shoja Z; Motahari P; Farhangi B
    Pathol Oncol Res; 2018 Apr; 24(2):329-337. PubMed ID: 28508329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Update on Ancillary Testing in the Evaluation of High-Grade Liver Tumors.
    Koehne de Gonzalez A; Lagana SM
    Surg Pathol Clin; 2018 Jun; 11(2):367-375. PubMed ID: 29751880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening and detection of hepatocellular carcinoma.
    Simpson HN; McGuire BM
    Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sal-like protein 4: an epithelial and germ cell marker.
    Jain D
    Hum Pathol; 2013 Jul; 44(7):1453. PubMed ID: 23773618
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of CD34 and factor VIII to diagnose hepatocellular carcinoma on fine needle aspirates.
    Gottschalk-Sabag S; Ron N; Glick T
    Acta Cytol; 1998; 42(3):691-6. PubMed ID: 9622689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features.
    Choi WT; Kakar S
    Adv Anat Pathol; 2018 Jul; 25(4):254-262. PubMed ID: 29649004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metastatic Hepatocellular Carcinoma into the Transverse Colon.
    Ofosu A; Ramai D; Kurtz LE; Genuth L; Reddy M
    J Gastrointest Cancer; 2019 Sep; 50(3):644-646. PubMed ID: 29611036
    [No Abstract]   [Full Text] [Related]  

  • 48. Biomarkers for Hepatocellular Carcinoma (HCC): An Update.
    Li D; Satomura S
    Adv Exp Med Biol; 2015; 867():179-93. PubMed ID: 26530367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Computational Selection of Metabolite Biomarkers Using Emerging Pattern Mining: A Case Study in Human Hepatocellular Carcinoma.
    Poezevara G; Lozano S; Cuissart B; Bureau R; Bureau P; Croixmarie V; Vayer P; Lepailleur A
    J Proteome Res; 2017 Jun; 16(6):2240-2249. PubMed ID: 28447453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma.
    Xu J; Li J; Zheng TH; Bai L; Liu ZJ
    Adv Clin Exp Med; 2016; 25(5):971-975. PubMed ID: 28028963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.
    Qin LX; Tang ZY
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):497-513. PubMed ID: 15205947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.
    Masuda T; Miyoshi E
    Clin Chem Lab Med; 2011 Jun; 49(6):959-66. PubMed ID: 21428856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Specific biomarkers for the diagnosis and prognosis of hepatocellular carcinoma].
    Wang HY
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):241-3. PubMed ID: 21805729
    [No Abstract]   [Full Text] [Related]  

  • 54. Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.
    Bao H; Su H
    Biomed Res Int; 2017; 2017():6049480. PubMed ID: 28835896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are biomarkers still helpful in hepatocellular carcinoma?
    Lamerz R
    Digestion; 2013; 87(2):118-20. PubMed ID: 23406724
    [No Abstract]   [Full Text] [Related]  

  • 56. Transcriptome Analysis of WHV/c-myc Transgenic Mice Implicates Cytochrome P450 Enzyme 17A1 as a Promising Biomarker for Hepatocellular Carcinoma.
    Wang F; Huang J; Zhu Z; Ma X; Cao L; Zhang Y; Chen W; Dong Y
    Cancer Prev Res (Phila); 2016 Sep; 9(9):739-49. PubMed ID: 27339169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma?
    Dhayat SA; Mardin WA; Köhler G; Bahde R; Vowinkel T; Wolters H; Senninger N; Haier J; Mees ST
    J Surg Oncol; 2014 Sep; 110(4):430-8. PubMed ID: 24895326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatocellular carcinoma: clinical features, evaluation and treatment.
    Khurshid H; Malik IA
    J Pak Med Assoc; 1995 May; 45(5):136-43. PubMed ID: 7563580
    [No Abstract]   [Full Text] [Related]  

  • 59. Spontaneous regression of hepatocellular carcinoma.
    Kondo S; Okusaka T; Ueno H; Ikeda M; Morizane C
    Int J Clin Oncol; 2006 Oct; 11(5):407-11. PubMed ID: 17058140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma.
    Vasuri F; Malvi D; Bonora S; Fittipaldi S; Renzulli M; Tovoli F; Golfieri R; Bolondi L; D'Errico A
    Histopathology; 2018 Feb; 72(3):414-422. PubMed ID: 28881044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.